LXEO files Form 144 to resell 11,374 vested shares

LXEO Form 144 filing reports planned resale of 11,374 common shares tied to restricted stock vesting.

Rhea-AI Filing Summary

LXEO Form 144 filing reports planned resale of 11,374 common shares tied to restricted stock vesting. The filing lists a restricted stock vesting transaction dated 02/17/2026 showing 11,374 shares as "Securities To Be Sold" and notes prior sales of 1,127 shares on 11/18/2025.

Insights

Securities Compliance Officer

Routine resale notice for vested restricted shares; administrative disclosure under Rule 144.

This filing lists 11,374 common shares associated with a restricted stock vesting event dated 02/17/2026, identified as "Securities To Be Sold." The submission follows standard resale-reporting practice under Rule 144.

Cash‑flow treatment is not stated; prior sales of 1,127 shares on 11/18/2025 are disclosed. Subsequent trading activity will depend on holder decisions and compliance with transfer restrictions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LXEO's Form 144 disclose about the shares?

It discloses a planned resale of 11,374 common shares tied to restricted stock vesting on 02/17/2026. The filing also reports prior sales of 1,127 shares on 11/18/2025, reflecting recent insider disposition activity.

Who is named in the LXEO Form 144 filing?

The filing names Richard N. Townsend and a brokerage address for Fidelity Brokerage Services LLC. It associates the resale with restricted stock vesting and lists the brokerage details provided in the notice.

Does the Form 144 state how the proceeds will be used?

The filing does not state a use of proceeds for the resale of shares. It records the number of shares tied to vesting and prior sales but provides no proceeds allocation information.

When were the restricted shares vested according to the filing?

The restricted stock vesting date is shown as 02/17/2026 for the 11,374 common shares listed as to be sold. That vesting date is the basis for the resale notice.

Does the Form 144 indicate recent insider sales for LXEO?

Yes; it lists a past sale of 1,127 shares dated 11/18/2025, indicating prior insider disposition within the three‑month reporting window.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001995218
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Lexeo Therapeutics, Inc.
SEC File Number	001-41855
Address of Issuer	345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NEW YORK 10010
Phone	(212) 547-9879
Name of Person for Whose Account the Securities are To Be Sold	Townsend Richard Nolan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11374	72585.46	72987327	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			11374	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard N. Townsend 345 Park Avenue South Floor 6 New York NY 10010	Common	11/18/2025	1127	10452.47

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Richard N. Townsend
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)